Corporate Strategy/Planning
Novartis to Complete Spinoff of Generic Drug Division
Gregory Daniels
Novartis’ generic drugs and biosimilars division will start trading on Wednesday as Sandoz. Courtesy Novartis Text size Swiss pharmaceutical firm ...